IL2 and fatty liver disease: Gut immune barrier alterations in duodenal tissue samples by T lymphocytes and Th1 cytokines, and pro-inflammatory biomarkers using CD4 Alexa Fluor 488 and IL-2 PE stain, were used to establish their different patterns in liver cirrhosis or hepatic steatosis.